Top Stories https://www.benzinga.com/views/taxonomy/term/138079 en The Week Ahead In Biotech: Spotlight On ESMO Conference https://www.benzinga.com/general/biotech/19/09/14460216/the-week-ahead-in-biotech-spotlight-on-esmo-conference <p>Biotech stocks put up a muted performance in the week ended Sept. 20 amid conference presentations and FDA approvals.</p> <p><strong>Johnson &amp; Johnson </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>)&#39;s Janssen unit received an FDA nod for label expansion for its prostate cancer drug Erleada, and <strong>Eisai Co., Ltd </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/esaly#OTC">ESALY</a>)&#39;s Lenvantinib in combination with <strong> Merck &amp; Co., Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrk#NYSE">MRK</a>)&#39;s <a href="https://www.benzinga.com/general/biotech/19/05/13722540/mercks-keytruda-vs-bristol-myers-squibbs-opdivo-in-q1-and-beyond">Keytruda</a> was approved for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient and who have disease progression following prior systemic therapy but are not candidates for curative surgery or radiation.</p> <p>Among the biotech IPOs, <strong>IGM Biosciences, Inc</strong>. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) made a <a href="https://www.benzinga.com/general/biotech/19/09/14442683/igm-biosciences-ipo-what-you-need-to-know">strong debut</a>, closing its first session with a gain of about 46% from its IPO price of $16.</p> <p>The following are&nbsp;key catalysts for&nbsp;biotech investors to keep an eye on in the unfolding week.</p> <h3>Conferences</h3> <ul> <li>2nd World Summit on Liver Cirrhosis and Hepatitis &ndash; Sept. 23-24&nbsp;in Tokyo</li> <li>11th Euro-Global Conference on Infectious Diseases &ndash; Sept. 23-24&nbsp;in London</li> <li>Ladenburg Thalmann 2019 Healthcare Conference &ndash; Sept. 24&nbsp;in New York</li> <li>15th World Conference on Cosmetic Dermatology &amp; Skin Diseases &ndash; Sept. 25-26&nbsp;in Lisbon</li> <li>World Cancer Research and Biomarkers Conference &ndash; Sept. 25-26&nbsp;in Toronto</li> <li>6th International Conference on Hypertension &amp; Healthcare &ndash; Sept. 26-28&nbsp;in London</li> <li>Cancer Therapy &amp; Biomarkers - Sept. 27-28&nbsp;in Lisbon</li> <li>6th European Rett Syndrome Conference &ndash; Sept. 27-28&nbsp;in Tampere</li> <li>European Society for Medical Oncology 2019 Conference &ndash; Sept. 27- Oct. 1 ...</li></ul><p><a href=https://www.benzinga.com/general/biotech/19/09/14460216/the-week-ahead-in-biotech-spotlight-on-esmo-conference alt=The Week Ahead In Biotech: Spotlight On ESMO Conference>Full story available on Benzinga.com</a></p> ABBV ALRN AMGN ARAV ASLN AVXL AZN Biotech CALA CKPT Earnings ESALY ESMO European Society for Medical Oncology GNCA GSK GTHX IBB IGMS IMMU INCY JNJ MRK News NVS PFE RHHBY RYTM SGEN TROV URGN XBI ZLAB ZYME Health Care Previews FDA Events Top Stories Trading Ideas General XBI US78464A8707 AMGN US0311621009 IBB US4642875565 IMMU US4529071080 INCY US45337C1027 SGEN US8125781026 AZN US0463531089 GSK US37733W1053 JNJ US4781601046 MRK US58933Y1055 NVS US66987V1098 PFE US7170811035 RHHBY US7711951043 AVXL ALRN TROV ESALY ABBV GNCA CALA RYTM CKPT ZYME URGN GTHX ZLAB ASLN ARAV IGMS News Earnings Biotech Health Care Previews FDA Events Top Stories Trading Ideas General Benzinga Sun, 22 Sep 2019 20:22:17 +0000 Shanthi Rexaline 14460216 at https://www.benzinga.com Roku's Rough Week: A Constructive Pullback For The Stock? https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14466823/rokus-rough-week-a-constructive-pullback-for-the-stock <p><strong>Roku Inc </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) shares have experienced a steady sell-off this week, culminating in a 20% drop on Friday. Here&rsquo;s a closer look at the fundamental headlines behind the sell-off and the stock&rsquo;s technical outlook heading into next week.</p> <h3>Negative Headlines</h3> <p><a href="https://www.benzinga.com/markets/cryptocurrency/19/09/14450610/facebooks-portal-tv-gives-roku-investors-pause">On Wednesday</a>, The Verge reported that&nbsp;<strong>Facebook, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fb#NASDAQ">FB</a>)&nbsp;is preparing to launch a clip-on camera for use in video calling, content co-watching and AR gaming. Facebook&rsquo;s Portal TV could be a major threat to Roku devices.</p> <p><a href="http://www.benzinga.com/analyst-ratings/analyst-color/19/09/14452864/how-facebook-comcast-just-shook-up-the-streaming-video-wars">That same day</a>,<strong> Comcast Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NYSE">CMCSA</a>) announced a new free set-top box for cord-cutters that could also be a direct competitor to Roku.</p> <h3>Wall Street Reacts</h3> <p>Several analysts stepped in to defend Roku following the negative headlines.</p> <p>D.A. Davidson analyst Tom Forte reiterated his Buy rating and $185 price target for Roku.</p> <p>&ldquo;We recommend investors purchase shares and take advantage of yesterday&#39;s pull-back, down roughly ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14466823/rokus-rough-week-a-constructive-pullback-for-the-stock alt=Roku&#039;s Rough Week: A Constructive Pullback For The Stock?>Full story available on Benzinga.com</a></p> Analyst Color CMCSA D.A. Davidson FB Guggenheim Jeffrey Wlodarczak Michael Morris News Pivotal Research ROKU Tom Forte Technicals Top Stories Analyst Ratings Tech Trading Ideas CMCSA US20030N1019 FB ROKU News Analyst Color Technicals Top Stories Analyst Ratings Tech Trading Ideas Benzinga Fri, 20 Sep 2019 18:47:19 +0000 Wayne Duggan 14466823 at https://www.benzinga.com More Bearish Tidings For The Hong Kong ETF https://www.benzinga.com/news/19/09/14462205/more-bearish-tidings-for-the-hong-kong-etf <p>Already under siege amid pro-democracy protests, the <strong>iShares MSCI Hong Kong ETF</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ewh#NYSE">EWH</a>) could see more downside, something options traders are betting.</p> <h3>What Happened</h3> <p>The protests commenced in the Chinese Special Administrative Region (SAR) several months ago following passage of bill that would&#39;ve paved the way for criminals there to be extradited to mainland China where they would face a more complex legal system and potentially stiffer punishments.</p> <p>While Hong Kong leaders have quashed that bill, the protests have carried on with demonstrators facing often hostile acts from local authorities.</p> <p>&ldquo;<a href="https://www.theguardian.com/world/amnesty-international">Amnesty International</a> has warned of an &#39;alarming pattern of violence used by Hong Kong police at anti-government demonstrations over the past ...</p><p><a href=https://www.benzinga.com/news/19/09/14462205/more-bearish-tidings-for-the-hong-kong-etf alt=More Bearish Tidings For The Hong Kong ETF>Full story available on Benzinga.com</a></p> EWH Hong Kong Short Ideas Emerging Market ETFs Options Top Stories Markets Trading Ideas ETFs EWH US4642868719 Short Ideas Emerging Market ETFs Options Top Stories Markets Trading Ideas ETFs Benzinga Fri, 20 Sep 2019 18:25:38 +0000 ETF Professor 14462205 at https://www.benzinga.com Large Option Trader Aggressively Dumping Netflix Calls https://www.benzinga.com/trading-ideas/short-ideas/19/09/14466617/large-option-trader-aggressively-dumping-netflix-calls <p><strong>Netflix Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>) shares tanked towards the end of this week as some negative headlines have rattled investors. Some large option traders were aggressively dumping Netflix calls on Friday as investors begin to focus on the launch of the <strong>Walt Disney Co</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) streaming service in November.</p> <h3>The Trades</h3> <p>On Friday morning, <a href="https://pro.benzinga.com?afmc=55">Benzinga Pro </a>subscribers received 11 option alerts related to unusually large Netflix trades. Among the most noteworthy of the trades was a series of six large orders executed between 10:02 a.m. and 10:04 a.m.</p> <p>Over a series of four trades, a trader sold 2,797 Netflix call options with a $285 strike price expiring on Oct. 15 near the bid prices of between $8.632 and $9.286.</p> <p>Mixed between those four trades were another two trades representing a total of 1,688 additional $285 Oct. 15 calls that changed hands at prices near the midpoint of the bid-ask spread.</p> <p>While trades at the midpoint are typically considered neutral, these trades are more bearish in nature given that they likely were executed by the same trader selling near the bid. Looking at the series of six trades that took place within a two-minute stretch, each ...</p><p><a href=https://www.benzinga.com/trading-ideas/short-ideas/19/09/14466617/large-option-trader-aggressively-dumping-netflix-calls alt=Large Option Trader Aggressively Dumping Netflix Calls>Full story available on Benzinga.com</a></p> AAPL DIS NFLX Short Ideas Options Top Stories Markets Trading Ideas AAPL US0378331005 NFLX US64110L1061 DIS US2546871060 Short Ideas Options Top Stories Markets Trading Ideas Benzinga Fri, 20 Sep 2019 18:16:23 +0000 Wayne Duggan 14466617 at https://www.benzinga.com 13 Stocks With Short Squeeze Potential https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14465833/13-stocks-with-short-squeeze-potential <p>One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a list of potential short squeeze stocks based on their high borrowing rates.</p> <p>A stock borrow fee is the percentage of a stock&rsquo;s value that brokers charge short sellers to borrow the stock. If supply of shares to borrow gets low, borrow fees tend to rise.</p> <p>&ldquo;While not all stocks with high borrow rates correlate with eventual short squeezes, looking at the pool of stocks with sudden and significant increases in their financing costs is a target rich environment for finding stocks with short squeeze potential,&rdquo; Dusaniwsy said.</p> <p>When a stock&rsquo;s borrow fees spike, it applies pressure to short sellers to ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14465833/13-stocks-with-short-squeeze-potential alt=13 Stocks With Short Squeeze Potential>Full story available on Benzinga.com</a></p> Analyst Color AXDX BYND CGC CLF CRWD HIIQ Ihor Dusaniwsky Long Ideas OSTK PAYS PD S3 Partners TELL TLRD TLRY ZM Top Stories Analyst Ratings Trading Ideas OSTK US6903701018 CLF US18683K1016 CGC HIIQ AXDX PD TLRD TELL TLRY US88688T1007 BYND ZM PAYS CRWD Long Ideas Analyst Color Top Stories Analyst Ratings Trading Ideas Benzinga Fri, 20 Sep 2019 16:30:09 +0000 Wayne Duggan 14465833 at https://www.benzinga.com Trump Denies Wrongdoing In Call With Foreign Leader; Congress Seeks Whistleblower Complaint https://www.benzinga.com/news/19/09/14465676/trump-denies-wrongdoing-in-call-with-foreign-leader-congress-seeks-whistleblower-complaint <p>President Donald Trump on Friday denied he made an improper or illegal promise to a foreign leader, dismissing the claim as &ldquo;fake news,&rdquo; as allegations emerged that Trump and his allies pressured the Ukrainian government to investigate Joe Biden, a potential Trump opponent in next year&rsquo;s election.</p> <h3>What Happened</h3> <p>The allegations appear to center on a July call in which Trump reportedly told Ukrainian President Volodymyr Zelensky that incomplete corruption investigations on Ukraine&#39;s part had inhibited relations between the two countries.</p> <p>While <a href="http://president.gov.ua/en/news/volodimir-zelenskij-proviv-telefonnu-rozmovu-z-prezidentom-s-56617">summaries of the call</a>&nbsp;haven&rsquo;t mentioned a specific corruption investigation, Trump lawyer Rudolph Giuliani has for months publicly encouraged the Ukrainian investigation of Biden, alleging, as Giuliani charged again on CNN this week, that Biden &ldquo;bribed the president of Ukraine&rdquo; to intervene in <a href="https://www.nytimes.com/2019/05/01/us/politics/biden-son-ukraine.html?module=inline">a probe of the business dealings of Biden&rsquo;s son</a>, Hunter.</p> <p>Giuliani <a href="https://www.politico.com/story/2019/09/19/giuliani-biden-ukraine-trump-1506009">acknowledged Thursday on CNN </a>that he asked Ukrainian officials to investigate Joe Biden.</p> <h3>Whistleblower Complaint Over &#39;Pitch Perfect&#39; Call</h3> <p>Questions about whether <a href="https://www.benzinga.com/topic/donald-trump">Trump </a>or his lawyers have sought to have Ukraine dig up dirt on Biden emerged following <a ...</p><p><a href=https://www.benzinga.com/news/19/09/14465676/trump-denies-wrongdoing-in-call-with-foreign-leader-congress-seeks-whistleblower-complaint alt=Trump Denies Wrongdoing In Call With Foreign Leader; Congress Seeks Whistleblower Complaint>Full story available on Benzinga.com</a></p> cnn Donald Trump Joe Biden News Rudy Giuliani The New York Times The Washington Post Ukraine Volodymyr Zelensky Politics Global Top Stories Media General News Politics Global Top Stories Media General Benzinga Fri, 20 Sep 2019 16:14:40 +0000 Dave Royse 14465676 at https://www.benzinga.com How To Find Small Caps That Actually Make Money https://www.benzinga.com/trading-ideas/long-ideas/19/09/14462412/how-to-find-small-caps-that-actually-make-money <p>Investors usually embrace small-cap stocks for growth and over the course of that indulgence, they&#39;re often willing to sacrifice profitability to attain that growth. Lack of profitability is tolerated (until it&#39;s not) throughout equity markets and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14458519/barclays-says-beyond-meat-has-the-beef-investors-crave">it&#39;s a luxury often afforded</a> to mid-sized and large-cap growth companies, so conventional wisdom says why not apply to small caps?</p> <h3>What Happened</h3> <p>Profitable or not, small caps are riskier than larger companies, but if lack of profitability is added into the equation, than the risks exponentially increase. For investors looking to dial back that risk profile while adding an element of quality to small-cap investing, the <strong>WisdomTree U.S. SmallCap Fund</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ees#NYSE">EES</a>) is an ETF that makes a lot of sense.</p> <p>EES follows the ...</p><p><a href=https://www.benzinga.com/trading-ideas/long-ideas/19/09/14462412/how-to-find-small-caps-that-actually-make-money alt=How To Find Small Caps That Actually Make Money>Full story available on Benzinga.com</a></p> EES Broad U.S. Equity ETFs Small Cap Analysis Top Stories Trading Ideas ETFs EES US97717W5629 Broad U.S. Equity ETFs Small Cap Analysis Top Stories Trading Ideas ETFs Benzinga Fri, 20 Sep 2019 15:40:16 +0000 ETF Professor 14462412 at https://www.benzinga.com Analyst: 'Short Squeeze Is Possible' In Twilio https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14465333/analyst-short-squeeze-is-possible-in-twilio <p><strong>Twilio Inc </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) shares are up 2.9% in the past two days following an <a href="https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14459954/twilios-multiple-contraction-a-function-of-confusion-morgan-stanley-says-in-upgrade">upgrade by Morgan Stanley</a>. S3 Partners analyst Ihor Dusaniwsky said the upgrade could potentially be the catalyst for a Twilio short squeeze.</p> <h3>The Numbers</h3> <p>Dusaniwsky said Twilio has the largest outstanding short position of any stock in the internet services and infrastructure group, with more than $1.73 billion in short interest. Despite Twilio&rsquo;s 20.9% sell-off in the past three months, Dusaniwsky said Twilio short sellers have registered more than $126.2 million in mark-to-market losses so far in 2019.</p> <p>Short sellers were aggressively selling Twilio shares in spring and early summer, with the stock&rsquo;s total number of shares shorted more than doubling to 8.23 million shares since the ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14465333/analyst-short-squeeze-is-possible-in-twilio alt=Analyst: &#039;Short Squeeze Is Possible&#039; In Twilio>Full story available on Benzinga.com</a></p> Analyst Color Ihor Dusaniwsky Long Ideas S3 Partners TWLO Top Stories Analyst Ratings Trading Ideas TWLO Long Ideas Analyst Color Top Stories Analyst Ratings Trading Ideas Benzinga Fri, 20 Sep 2019 15:21:38 +0000 Wayne Duggan 14465333 at https://www.benzinga.com MKM Initiates Mixed Coverage Of The Cannabis Sector, Most Bullish On Hexo https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14464738/mkm-initiates-mixed-coverage-of-the-cannabis-sector-most-bullish-on-hexo <p>The cannabis group received more attention from Wall Street when a top firm initiated coverage on eight cannabis stocks. However, the analyst coverage is mixed, suggesting stock selection is critical for cannabis investors.</p> <h3>The Analyst</h3> <p>MKM Partners analyst <a href="https://www.tipranks.com/analysts/william-kirk">Bill Kirk</a> initiated coverage of the following stocks:</p> <ul> <li><strong>Acreage Holdings Inc</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/acrgf#OTC">ACRGF</a>), Buy rating, $17 target.</li> <li><strong>Canopy Growth Corp</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NYSE">CGC</a>), Neutral rating, C$33 ($24.85) target.</li> <li><strong>Curaleaf Holdings Inc</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/curlf#OTC">CURLF</a>), Sell rating, C$5 ($3.77) target.</li> <li><strong>Constellation Brands, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stz#NYSE">STZ</a>), Buy rating, $263 target.</li> <li><strong>Hexo Corp </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hexo#NYSE">HEXO</a>), Buy rating, CA$12 ($9.04) target.</li> <li><strong>Tilray Inc </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>), Neutral rating, $34 target.</li> <li><strong>Cronos Group Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cron#NASDAQ">CRON</a>), Neutral rating, CA$14 ($10.54) target.</li> <li><strong>Aurora Cannabis Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acb#NYSE">ACB</a>), Sell rating, CA$5 ($3.77) target.</li> </ul> <p><a href="http://benzingacannabisconference.com/"><strong><em>Click here</em></strong></a><strong><em> for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.</em></strong></p> <h3>The Theses</h3> <p>Here&rsquo;s a sampling of what Kirk had to say about each name.</p> <p><strong>Acreage:</strong> Kirk said the conditional Canopy buyout implies Acreage shares are currently significantly undervalued.</p> <p>&ldquo;A contractual 0.5818 exchange for Canopy shares on 142.6mn Acreage shares implies a ~US$17 value for ACRG, compared to the current Acreage share price of ~$8,&rdquo; Kirk wrote.</p> <p>He said there is certainly uncertainty surrounding U.S. legalization, but not enough uncertainty to justify a roughly 50% discount to the buyout price.</p> <p><strong>Canopy Growth: </strong>Kirk said financial support from Constellation is helpful, but Canopy will likely continue to deal with cultivation growing pains.</p> <p>&ldquo;Unlike market expectations, we do not expect Canopy to become a profitable organization by FY2022 (on EPS),&rdquo; ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14464738/mkm-initiates-mixed-coverage-of-the-cannabis-sector-most-bullish-on-hexo alt=MKM Initiates Mixed Coverage Of The Cannabis Sector, Most Bullish On Hexo>Full story available on Benzinga.com</a></p> ACB ACRGF Analyst Color Bill Kirk Cannabis CGC CRON CURLF HEXO MKM Partners MO STZ TLRY Price Target Initiation Top Stories Markets Analyst Ratings MO US02209S1033 STZ US21036P1084 CGC ACB CRON TLRY US88688T1007 HEXO CURLF ACRGF Analyst Color Cannabis Price Target Initiation Top Stories Markets Analyst Ratings Benzinga Fri, 20 Sep 2019 14:16:28 +0000 Wayne Duggan 14464738 at https://www.benzinga.com Too Good To Be True: The Rise And Fall Of MoviePass https://www.benzinga.com/news/19/09/14443762/too-good-to-be-true-the-rise-and-fall-of-moviepass <p>After a wild eight-year ride, <strong>Helios and Matheson Analytics Inc </strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/hmny#OTC">HMNY</a>) officially shut down its subscription movie theater service MoviePass last weekend.</p> <p>In a matter of years, MoviePass went from an unknown startup to a major disruptive force to a financial albatross for parent company Helios.</p> <p>Here&rsquo;s a <a href="https://www.benzinga.com/news/18/10/12335662/one-year-later-the-rise-and-fall-of-helios-and-matheson">look back</a> at MoviePass&rsquo; rise, downfall and lasting impact on the industry.</p> <h3>Humble Beginnings</h3> <p>MoviePass launched back in 2011, charging early customers $40 per month to see one movie per day of the subscriber&rsquo;s choice at any theater.</p> <p>When the company&rsquo;s first test service launched in San Francisco, 19,000 members initially signed up, grabbing the attention of the major theater chains.</p> <p>In 2012, MoviePass began a national beta test of its service, which ranged in price between $29 and $34 depending on location.</p> <p>After limited early success, CEO Mitch Lowe joined MoviePass in June 2016. Lowe&rsquo;s early strategy involved dramatically cutting pricing in an effort to beef up subscriber growth, and the effort worked like a charm.</p> <h3>Helios ...</h3><p><a href=https://www.benzinga.com/news/19/09/14443762/too-good-to-be-true-the-rise-and-fall-of-moviepass alt=Too Good To Be True: The Rise And Fall Of MoviePass>Full story available on Benzinga.com</a></p> AMC CNK HMNY Mitch Lowe MoviePass Education Top Stories Tech Media General CNK US17243V1026 HMNY AMC Education Top Stories Tech Media General Benzinga Fri, 20 Sep 2019 13:35:21 +0000 Wayne Duggan 14443762 at https://www.benzinga.com McDermott Up 50% After Takeover Bids For Lummus Technology https://www.benzinga.com/m-a/19/09/14464099/mcdermott-up-50-after-takeover-bids-for-lummus-technology <p><strong>McDermott International, Inc. </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdr#NYSE">MDR</a>) shares are trading sharply higher after the company announced it will explore strategic alternatives for Lummus Technology.</p> <p>McDermott recently received unsolicited offers to acquire Lummus with a valuation of over $2.5 billion.</p> <p>McDermott&#39;s Lummus Technology is a licensor of proprietary petrochemicals, refining, gasification and gas processing technologies.</p> <p>&quot;The process of exploring strategic alternatives is part of our ongoing efforts intended to improve McDermott&#39;s capital structure, and we plan ...</p><p><a href=https://www.benzinga.com/m-a/19/09/14464099/mcdermott-up-50-after-takeover-bids-for-lummus-technology alt=McDermott Up 50% After Takeover Bids For Lummus Technology>Full story available on Benzinga.com</a></p> Lummus Technology M&A MDR News Top Stories MDR PA5800371096 News M&A Top Stories Benzinga Fri, 20 Sep 2019 13:06:40 +0000 Tanzeel Akhtar 14464099 at https://www.benzinga.com POTX: A Potent Pot ETF Debuts https://www.benzinga.com/markets/cannabis/19/09/14462339/potx-a-potent-pot-etf-debuts <p>Cannabis investing enthusiasts now have a sixth exchange traded fund to consider following the Thursday debut of the <strong>Global X Cannabis ETF</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/potx#NASDAQ">POTX</a>).</p> <p>POTX tracks the Cannabis Index, making it the third passively managed fund in the cannabis ETF space.</p> <h3>What Happened</h3> <p>Measuring the success of the U.S.-listed cannabis beyond the <strong>ETFMG Alternative Harvest ETF</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mj#NYSE">MJ</a>), the group&#39;s largest and oldest fund, is difficult at this point because, including POTX, five of those six ETFs have come to market since April of this year.</p> <p>Specific to POTX, its issuer, Global X, is not only a well-known ETF sponsor, but one that has proven adept <a href="https://www.benzinga.com/trading-ideas/long-ideas/19/02/13165940/silver-miners-etf-is-trying-to-shine">in the field of thematic funds</a>, amassing impressive assets under management tallies with ETFs offering exposure to an array of investment niches, <a href="https://www.benzinga.com/trading-ideas/long-ideas/19/04/13549185/another-cloud-computing-etf-arrives">such as cloud computing</a>, fintech, social media and many more.</p> <p><a href="http://benzingacannabisconference.com/"><strong><em>Click here</em></strong></a><strong><em>&nbsp;for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.</em></strong></p> <h3>Why It&#39;s Important</h3> <p>POTX debuts ...</p><p><a href=https://www.benzinga.com/markets/cannabis/19/09/14462339/potx-a-potent-pot-etf-debuts alt=POTX: A Potent Pot ETF Debuts>Full story available on Benzinga.com</a></p> ACB Cannabis CGC CRON Long Ideas MJ News POTX Sector ETFs New ETFs Top Stories Markets Trading Ideas ETFs CGC ACB MJ CRON POTX Long Ideas Sector ETFs News Cannabis New ETFs Top Stories Markets Trading Ideas ETFs Benzinga Fri, 20 Sep 2019 12:59:47 +0000 ETF Professor 14462339 at https://www.benzinga.com Twilio's Multiple Contraction A Function Of 'Confusion,' Morgan Stanley Says In Upgrade https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14459954/twilios-multiple-contraction-a-function-of-confusion-morgan-stanley-says-in-upgrade <p>Shares of <strong>Twilio Inc</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twlo#NYSE">TWLO</a>) are trading near six-month lows, and the recent pullback may be a function of &quot;confusion&quot; related to its growth outlook, according to Morgan Stanley.</p> <h3>The Analyst</h3> <p><a href="https://www.tipranks.com/analysts/meta-marshall">Meta Marshall</a> upgraded Twilio&nbsp;from Equal-weight to Overweight with a price target lifted from $130 to $135.</p> <h3>The Thesis</h3> <p><a href="http://benzinga.com/stock/twlo">Twilio</a> should be considered a &quot;visionary&quot; communications company as it looks to remove constraints plaguing the traditional B2C communication landscape, Marshall said in a Thursday upgrade note. (See his track record <a href="http://www.tipranks.com/analysts/meta-marshall">here</a>.)&nbsp;</p> <p>Investors are confused about Twilio&#39;s growth, since its new and higher margin products like ...</p><p><a href=https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14459954/twilios-multiple-contraction-a-function-of-confusion-morgan-stanley-says-in-upgrade alt=Twilio&#039;s Multiple Contraction A Function Of &#039;Confusion,&#039; Morgan Stanley Says In Upgrade>Full story available on Benzinga.com</a></p> Analyst Color Meta Marshall Morgan Stanley TWLO Upgrades Price Target Top Stories Analyst Ratings TWLO Analyst Color Upgrades Price Target Top Stories Analyst Ratings Benzinga Thu, 19 Sep 2019 18:06:15 +0000 Jayson Derrick 14459954 at https://www.benzinga.com Large Morgan Stanley Option Traders Make Bullish Bets Following Fed Commentary https://www.benzinga.com/trading-ideas/long-ideas/19/09/14460175/large-morgan-stanley-option-traders-make-bullish-bets-following-fed-commentary <p>Big bank stocks experienced mixed trading on Thursday morning following the Federal Reserve&rsquo;s <a href="https://www.benzinga.com/news/19/09/14453271/fed-issues-second-rate-cut-of-2019">second rate cut of the year</a>. However, <strong>Morgan Stanley</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ms#NYSE">MS</a>) definitely had some large option traders&rsquo; attention following the Fed decision.</p> <h3>The Trades</h3> <p>On Thursday morning, <a href="https://pro.benzinga.com?afmc=55">Benzinga Pro</a> subscribers received two option alerts related to unusually large Morgan Stanley trades:</p> <p>At 9:33 a.m., a trader bought 1,901 Morgan Stanley call options with a $46 strike price expiring on Nov. 15 near the ask price at 97.1 cents. The trade represented a $184,987 bullish bet.</p> <p>Less than a minute later, likely the same trader bought another 7,331 Morgan Stanley of the same $46 Nov. 15 call options near the ask price at $1.011. The second trade represented a $741,164 bullish bet.</p> <p>Together, the two trades represented a $926,151 total bet that Morgan Stanley shares have at least ...</p><p><a href=https://www.benzinga.com/trading-ideas/long-ideas/19/09/14460175/large-morgan-stanley-option-traders-make-bullish-bets-following-fed-commentary alt=Large Morgan Stanley Option Traders Make Bullish Bets Following Fed Commentary>Full story available on Benzinga.com</a></p> Long Ideas MS Options Top Stories Federal Reserve Markets Trading Ideas MS US6174464486 Long Ideas Options Top Stories Federal Reserve Markets Trading Ideas Benzinga Thu, 19 Sep 2019 17:14:57 +0000 Wayne Duggan 14460175 at https://www.benzinga.com Making History: Private Iowa College Attempts To Change Higher Education Pricing Landscape https://www.benzinga.com/general/education/19/09/14457561/making-history-private-iowa-college-attempts-to-change-higher-education-pricing-landscape <p>Venture into the middle of the Iowa prairie and you&rsquo;ll find a private college that may swiftly shift the debate about the costs of college on a national scale.</p> <p>Central College in Pella, Iowa, announced a $20,000 tuition cut that takes effect in fall 2020.</p> <p>The liberal arts college, which serves approximately 1,100 undergraduates, is lowering tuition from $38,600 to $18,600 for the fall 2020 academic year.</p> <p>The total 2020 published cost, with room and board &mdash;$10,280 &mdash; now totals $28,880. Last year, Central&rsquo;s published price with tuition, room and board was $48,880.</p> <h3>&#39;Tuition Price Is A Barrier&#39;</h3> <p>The landmark drop brings clarity to a price-sensitive national market and attempts to eliminate the &ldquo;sticker shock&rdquo; that most prospective students and families encounter. In the past, the college offered copious amounts of financial aid and scholarships in order to mitigate the pinch that families feel and shore up its enrollment numbers.</p> <p>But many families see the high &ldquo;sticker&rdquo; price and quickly look elsewhere, never even bothering to find out how much aid they might be able to obtain, or how much they might have to actually pay, said Ken Redd, the senior director of research and policy analysis at the National Association of ...</p><p><a href=https://www.benzinga.com/general/education/19/09/14457561/making-history-private-iowa-college-attempts-to-change-higher-education-pricing-landscape alt=Making History: Private Iowa College Attempts To Change Higher Education Pricing Landscape>Full story available on Benzinga.com</a></p> Central College Ken Redd Mark Putnam Education Top Stories Exclusives Interview General Education Top Stories Exclusives Interview General Benzinga Thu, 19 Sep 2019 15:29:37 +0000 Melissa Brock 14457561 at https://www.benzinga.com